Drug Master Files for: cilostazol
✉ Email this page to a colleague
cilostazol Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
16645 | A | II | 6/15/2003 | WAVELENGTH ENTERPRISES LTD | CILOSTAZOL |
16722 | A | II | 7/24/2003 | TEVA PHARMACEUTICAL INDUSTRIES LTD | CILOSTAZOL USP |
16876 | A | II | 10/2/2003 | GLENMARK PHARMACEUTICALS LTD | CILOSTAZOL USP |
17050 | A | II | 12/22/2003 | DIPHARMA FRANCIS SRL | CILOSTAZOL |
17372 | I | II | 5/12/2004 | SA AJINOMOTO OMNICHEM NV | CILOSTAZOL |
17475 | I | II | 6/22/2004 | ALEMBIC PHARMACEUTICALS LTD | CILOSTAZOL |
17973 | I | II | 1/6/2004 | UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) | CILOSTAZOL |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information